DEPDC1B and lip and oral cavity carcinoma: E2 is known to interact with and downregulate several proteins (CPB2, HSPBAP1, RBM26, etc.), one of them being DEPDC1B, which recently was found to be overexpressed in oral cancer [16, 17].